SCHEMBL22508191

SCHEMBL22508191

CC(C)Cc1cccc(CC(C)S)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.42
GABRB2 P47870 2/20 0.42
PNMT P11086 1/20 0.42
TAAR1 Q96RJ0 4/20 0.40
SLC6A2 P23975 2/20 0.40
MAOA P21397 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
CYP2A6 P11509 1/20 0.40
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
HTR2A P28223 2/20 0.39
HTR2C P28335 2/20 0.39
HTR2B P41595 2/20 0.39
CTSS P25774 1/20 0.36
CTSK P43235 1/20 0.36
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GRIN1 Q05586 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8539519 0.89 GABRA1 (0.50) GABRA1GABRB2PNMTTAAR1SLC6A2
SCHEMBL24819489 0.81 HTR2A (0.48) GABRA1GABRB2SIGMAR1CYP2A6HTR2A
SCHEMBL22579846 0.81 TAAR1 (0.48) PNMTTAAR1SLC6A2MAOASLC6A4
SCHEMBL9248105 0.80 HTR2A (0.44) GABRA1GABRB2PNMTTAAR1SLC6A2
SCHEMBL28486515 0.79 GABRA1 (0.40) GABRA1GABRB2PNMTTAAR1SLC6A2
SCHEMBL27209026 0.79 TDP1 (0.46) GABRA1GABRB2PNMTTAAR1SLC6A2
SCHEMBL7528532 0.79 GABRA1 (0.40) GABRA1GABRB2PNMTTAAR1SLC6A2
SCHEMBL19368039 0.79 GABRA1 (0.44) GABRA1GABRB2PNMTTAAR1SLC6A2
SCHEMBL13430091 0.79 IDO1 (0.46) PNMTTAAR1SLC6A2MAOASLC6A4
SCHEMBL20353178 0.79 PNMT (0.69) PNMTTAAR1SLC6A2SLC6A4SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020205564-A1 CYTOTOXIC BIS-BENZODIAZEPINE DERIVATIVES AND CONJUGATES THEREOF WITH CELL-BINDING AGENTS FOR INHIBITING ABNORMAL CELL GROWTH OR FOR TREATING PROLIFERATIVE DISEASES IMMUNOGEN, INC. (US) 2020-10-08 WO disclosed